Precision BioSciences to Present at Needham Healthcare Conference
Event summary
- Precision BioSciences (DTIL) will participate in the 25th Annual Needham Virtual Healthcare Conference.
- The conference runs April 13-16, 2026, with Precision BioSciences’ presentation scheduled for Tuesday, April 14, 2026, at 9:30 AM ET.
- A replay of the presentation will be available on the company’s website following the event.
- Precision BioSciences is utilizing its ARCUS® platform for in vivo gene editing therapies.
The big picture
Precision BioSciences, a clinical-stage gene editing company, is seeking to gain visibility and investor confidence amidst a crowded and rapidly evolving gene editing sector. The Needham Healthcare Conference provides a platform to showcase the ARCUS platform and its in vivo gene editing therapies, which target high unmet needs. Success will depend on demonstrating clinical efficacy and differentiation from competitors like CRISPR Therapeutics and Intellia Therapeutics.
What we're watching
- Investor Relations
- The conference participation signals an ongoing effort to engage with investors and analysts, potentially driven by the need to maintain or increase valuation in a competitive gene editing landscape.
- Clinical Progress
- The content of the presentation will be scrutinized for updates on the PBGENE-HBV and PBGENE-DMD programs, as progress in these clinical trials is critical to the company’s near-term outlook.
- Platform Adoption
- The success of Precision BioSciences hinges on broader adoption of the ARCUS platform; the conference provides an opportunity to articulate the platform’s advantages and address any lingering technical or commercial concerns.
Related topics